Effect of Bioflor on Gut Microbiota in Proton-Pump Inhibitor Users
Key facts
- Who runs it
- Seoul National University Hospital
- Where
- South Korea3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 80 people enrolled
- Started
- 18 Jul 2024
- Ended
- 18 Sept 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Saccharomyces Boulardii 250 MG
- Proton Pump Inhibitors (PPI)
- Record updated
- 1 October 2026
Who can take part
- Age
- 19 years to 79 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Voluntary written informed consent to participate in this clinical trial
- Age 19 to 79 years
- No history of PPI use within 2 months prior to obtaining consent
- BMI between 18.5 and 30.0 kg/m², and body weight ≥ 50 kg
Who cannot take part
- Antibiotic use within the prior 3 months
- Use of mucosal protective agents, NSAIDs, probiotics, or other agents/drugs altering gut microbiota function, lactulose, other antacids, GI motility-enhancing agents, or enemas within the prior 4 weeks
- Antifungal medication use within 14 days prior to enrollment
- History of Clostridioides difficile infection within 2 years prior to enrollment
- Significant change in dietary habits within 30 days prior to study participation, as assessed by the investigator
- New drug prescription within 2 weeks prior to enrollment
- History of gastrointestinal or abdominal surgery
- Immunocompromised individuals, or history of inflammatory bowel disease (Crohn's disease or ulcerative colitis)
- Any other condition that, in the investigator's judgment, makes the participant unsuitable for study participation
- Pregnant or breastfeeding women
- Presence of a central venous catheter
- Current smoker
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Proton-pump inhibitors (PPIs) are widely used to treat acid-related stomach problems, such as heartburn and acid reflux. Long-term use of PPIs has been linked to changes in the gut bacteria and fungi (called the gut microbiota), which may contribute to digestive side effects. Bioflor® is a probiotic product containing a yeast called Saccharomyces boulardii, which has been used to help with various digestive problems. However, little is known about how Bioflor affects the gut microbiota in people who are taking PPIs.
Read full original descriptionShow less
This study enrolled three groups of adults at four hospitals/research centers in Korea: a control group without digestive symptoms who were not taking a PPI, a group of patients with reflux symptoms who started taking a PPI alone, and a group of patients who started taking a PPI together with Bioflor for 8 weeks. Participants completed symptom questionnaires and provided stool samples before and after treatment, which were analyzed to study changes in gut bacteria and fungi.
The purpose of this study was to compare gut microbiota composition and digestive symptoms between PPI users who did and did not take Bioflor, in order to better understand the role of Bioflor in people taking PPIs.
The 3 groups in the trial
- ControlNo study treatment, for comparison
Healthy participants without GERD symptoms or need for PPI treatment. The Control group is not subject to randomization.
- Case1Existing treatment, for comparison
Patients with GERD/NERD symptoms starting PPI treatment, without Bioflor. Randomized 1:1 with Case 2.
Treatment: Proton Pump Inhibitors (PPI)
- Case2Treatment being tested
Patients with GERD/NERD symptoms starting PPI treatment combined with Bioflor (2 capsules twice daily for 8 weeks). Randomized 1:1 with Case 1.
Treatment: Saccharomyces Boulardii 250 MG and Proton Pump Inhibitors (PPI)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Saccharomyces Boulardii Probiotics (Bioflor®) on Gut Microbiota in Proton-pump Inhibitor User
- Record updated
- 1 October 2026